Introduction
Private equity has become an increasingly influential force in health care, and its expansion has triggered a serious policy debate about what happens when financial investors play a larger role in the delivery of medical services. In general, private equity firms raise capital from investors, buy ownership stakes in companies, restructure operations, and seek to increase value over a relatively short time horizon. In health care, this model has been applied to physician practices, hospitals, nursing facilities, emergency departments, anesthesia groups, specialty clinics, and other organizations.
The American College of Physicians (ACP) has previously raised concerns about the growing presence of financial profit motives in medicine. This position paper builds on that work and focuses specifically on the regulatory framework surrounding private equity and broader corporatization in health care. The central question is not whether investment is inherently good or bad, but whether current oversight is strong enough to protect patients, physicians, and the integrity of clinical decision making.
